Mosseri Marlio Charles's Form 4 filing
Nuvectis Pharma, Inc. (NVCT) · filed Jul 24, 2023
- Accession no.
- 0001104659-23-083470
- Filed
- Jul 24, 2023
- Trade date
- Jul 20-21, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $119.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mosseri Marlio CharlesCIK 0001806384 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 20, 2023 | Common Stock | PPurchaseAcquired | +5,394 | $14.40 | +$77,673.6 | 2,577,156 | Direct | |
| Jul 21, 2023 | Common Stock | PPurchaseAcquired | +2,844 | $14.61 | +$41,550.84 | 2,580,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.